Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma

难治性高危神经母细胞瘤的分子特征

基本信息

  • 批准号:
    10470672
  • 负责人:
  • 金额:
    $ 37.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The goal of this project is to identify molecular characteristics of multi-drug resistance in high-risk neuroblastoma patients with single-cell technology. We propose a paradigm-shift approach to map mutations into a single cell and identify sub-clones by molecular similarity of individual cells. Neuroblastoma is the common solid tumor in children, and it accounts for 15% of deaths from cancer in children. Here, we propose to identify multidrug-resistant mutations with Next Generation Sequencing (NGS) based on mutation frequency changes (from minority to majority) due to treatment selection. These NGS-identified mutations will be localized into individual cells with targeted single-cell RNA-seq to show that these mutations exist in a clone (a group of single-cells) and the clones expand during treatment. Finally, the resistant sub-clones will be isolated or generated for functional assays and distributed to research community. This approach shifts the paradigm of tumor molecular characterization by clustering molecularly similar cells into a clone rather than isolating a clone (often with experimental bias) for characterization. The results have direct and immediate impacts on current treatment of neuroblastoma. The molecular profiles of resistant clones can be developed into sensitive PCR assays for early detection of drug-resistance at diagnosis, and for personalized therapies to overcome treatment resistance at specific patients (who have specific sub-clones during chemotherapy). The single-cell approach that we develop in this proposal would be directly relevant to studies of other childhood and adult cancers as well.
 描述(申请人提供):本项目的目的是利用单细胞技术鉴定高危神经母细胞瘤患者多药耐药的分子特征。我们提出了一种范式转换的方法来映射到一个单一的细胞突变,并确定单个细胞的分子相似性的亚克隆。神经母细胞瘤是儿童常见的实体瘤,占儿童癌症死亡人数的15%。在这里,我们建议根据治疗选择导致的突变频率变化(从少数到多数),使用下一代测序(NGS)识别多药耐药突变。这些NGS鉴定的突变将被定位到具有靶向单细胞RNA-seq的单个细胞中,以显示这些突变存在于克隆(一组单细胞)中,并且克隆在治疗期间扩增。最后,将分离或产生抗性亚克隆用于功能测定并分发给研究社区。这种方法通过将分子相似的细胞聚集成克隆而不是分离克隆(通常具有实验偏倚)进行表征,从而改变了肿瘤分子表征的范式。这些结果对目前神经母细胞瘤的治疗有直接和直接的影响。耐药克隆的分子谱可以开发成敏感的PCR检测,用于在诊断时早期检测耐药性,并用于个性化治疗,以克服特定患者(在化疗期间具有特定亚克隆)的治疗耐药性。我们在这项提案中开发的单细胞方法也将与其他儿童和成人癌症的研究直接相关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John Zhong其他文献

John Zhong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John Zhong', 18)}}的其他基金

Large scale single-cell gene rearrangement detection with a microfluidic device
利用微流控装置进行大规模单细胞基因重排检测
  • 批准号:
    10031278
  • 财政年份:
    2020
  • 资助金额:
    $ 37.84万
  • 项目类别:
Large scale single-cell gene rearrangement detection with a microfluidic device
利用微流控装置进行大规模单细胞基因重排检测
  • 批准号:
    10737781
  • 财政年份:
    2020
  • 资助金额:
    $ 37.84万
  • 项目类别:
Large scale single-cell gene rearrangement detection with a microfluidic device
利用微流控装置进行大规模单细胞基因重排检测
  • 批准号:
    10468561
  • 财政年份:
    2020
  • 资助金额:
    $ 37.84万
  • 项目类别:
Large scale single-cell gene rearrangement detection with a microfluidic device
利用微流控装置进行大规模单细胞基因重排检测
  • 批准号:
    10454909
  • 财政年份:
    2020
  • 资助金额:
    $ 37.84万
  • 项目类别:
Supplement: Large scale single-cell gene rearrangement detection with a microfluidic device
补充:利用微流控装置进行大规模单细胞基因重排检测
  • 批准号:
    10522287
  • 财政年份:
    2020
  • 资助金额:
    $ 37.84万
  • 项目类别:
Large scale single-cell gene rearrangement detection with a microfluidic device
利用微流控装置进行大规模单细胞基因重排检测
  • 批准号:
    10202529
  • 财政年份:
    2020
  • 资助金额:
    $ 37.84万
  • 项目类别:
Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma
难治性高危神经母细胞瘤的分子特征
  • 批准号:
    9247150
  • 财政年份:
    2016
  • 资助金额:
    $ 37.84万
  • 项目类别:
Multi-phase Microfluidic Devices for Characterization of Circulating Tumor Cells
用于表征循环肿瘤细胞的多相微流体装置
  • 批准号:
    8658772
  • 财政年份:
    2012
  • 资助金额:
    $ 37.84万
  • 项目类别:
Multi-phase Microfluidic Devices for Characterization of Circulating Tumor Cells
用于表征循环肿瘤细胞的多相微流体装置
  • 批准号:
    8657926
  • 财政年份:
    2012
  • 资助金额:
    $ 37.84万
  • 项目类别:
Multi-phase Microfluidic Devices for Characterization of Circulating Tumor Cells
用于表征循环肿瘤细胞的多相微流体装置
  • 批准号:
    8843387
  • 财政年份:
    2012
  • 资助金额:
    $ 37.84万
  • 项目类别:

相似海外基金

Developing text message interventions tailored to psychological characteristics to improve access to smoking cessation treatment.
制定适合心理特征的短信干预措施,以改善获得戒烟治疗的机会。
  • 批准号:
    23K12907
  • 财政年份:
    2023
  • 资助金额:
    $ 37.84万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The importance of follow-ups: Characteristics in a community follow-up group that help or hinder the maintenance of treatment gains for children with ADHD
随访的重要性:社区随访小组的特征有助于或阻碍维持多动症儿童的治疗成果
  • 批准号:
    486651
  • 财政年份:
    2022
  • 资助金额:
    $ 37.84万
  • 项目类别:
    Studentship Programs
A Retrospective Cohort Study of the Clinicopathological and Treatment Characteristics Associated with the Development of Prostate Cancer Metastases to the Liver
与前列腺癌肝转移相关的临床病理学和治疗特征的回顾性队列研究
  • 批准号:
    486231
  • 财政年份:
    2022
  • 资助金额:
    $ 37.84万
  • 项目类别:
    Studentship Programs
Communication characteristics related to shared decision-making in the treatment of elderly patients with cancer
老年癌症患者治疗中与共同决策相关的沟通特征
  • 批准号:
    21K10761
  • 财政年份:
    2021
  • 资助金额:
    $ 37.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Substance use treatment needs, characteristics, and outcomes among emerging adults experiencing homelessness: A mixed-methods study
无家可归的新兴成年人的药物使用治疗需求、特征和结果:一项混合方法研究
  • 批准号:
    10398002
  • 财政年份:
    2021
  • 资助金额:
    $ 37.84万
  • 项目类别:
Effects on aging of mechanical characteristics of bamboo caused by conditions of harvest, preservation and treatment method, and usage environment
采收条件、保存处理方法、使用环境对竹材力学性能老化的影响
  • 批准号:
    21K14292
  • 财政年份:
    2021
  • 资助金额:
    $ 37.84万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Selection of bone marrow ALDH bright cells for treatment of pulmonary fibrosis focusing on changes in bone marrow characteristics
骨髓ALDH亮细胞治疗肺纤维化的选择重点关注骨髓特性的变化
  • 批准号:
    20K08519
  • 财政年份:
    2020
  • 资助金额:
    $ 37.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of donor plasma and recipient characteristics on convalescent plasma treatment outcome of COVID-19
供体血浆和受体特征对 COVID-19 恢复期血浆治疗结果的影响
  • 批准号:
    10225219
  • 财政年份:
    2019
  • 资助金额:
    $ 37.84万
  • 项目类别:
Pathophysiology of developmental disorders with sensory characteristics unique to low birthweight infants and strategies for their treatment
低出生体重儿特有的感觉特征发育障碍的病理生理学及其治疗策略
  • 批准号:
    19K14177
  • 财政年份:
    2019
  • 资助金额:
    $ 37.84万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Automatic Volumetric Treatment Response Assessment and Determination of Regional Genetic Characteristics in Glioblastoma
自动容量治疗反应评估和胶质母细胞瘤区域遗传特征的确定
  • 批准号:
    10096345
  • 财政年份:
    2019
  • 资助金额:
    $ 37.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了